-
Something wrong with this record ?
The mechanisms of inhibition of frog endplate currents with homologous derivatives of the 1,1-dimethyl-3-oxybutyl phosphonic acid
E. Pryazhnikov, A. Ostroumov, O. Druginina, F. Vyskočil, A. Skorinkin
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Allosteric Regulation drug effects MeSH
- Cholinergic Antagonists pharmacology MeSH
- Phosphorous Acids pharmacology MeSH
- Membrane Potentials drug effects MeSH
- Motor Endplate drug effects physiology MeSH
- Rana pipiens MeSH
- Ranidae physiology MeSH
- Receptors, Cholinergic metabolism MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The mode of inhibition of endplate currents by four esters of 1,1-dimethyl-3-oxybutyl phosphonic acid with different lipophilicities and molecule lengths were estimated by mathematical modeling based on previous electrophysiological data supplemented by several experiments with rhythmic stimulation. The aim was to discriminate between their receptor and non-receptor effects. It was shown that all esters have a two-component mechanism of depression: inhibition of the receptor open channel and allosteric modulation of the receptor-channel complex. The ratio of both functional components depends on the length and lipophilicity of the esters. Short and less lipophilic esters mostly act as open channel inhibitors and the rate of inhibition substantially depends on the rate of stimulation, i. e. probability of the receptor-channel opening. As the length of the ester radicals and their lipophilicity increased, these compounds were more active as allosteric receptor inhibitors, probably hindering the function of nAChRs from the lipid annulus.
Institute of Informatics Kazan Russia
Kazan Federal University Kazan Russia
Kazan Institute of Biochemistry and Biophysics RAS Kazan Russia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13033331
- 003
- CZ-PrNML
- 005
- 20131025121318.0
- 007
- ta
- 008
- 131015s2012 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932314 $2 doi
- 035 __
- $a (PubMed)22670693
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Pryazhnikov, E. $u Kazan State Medical University, Kazan Russia
- 245 14
- $a The mechanisms of inhibition of frog endplate currents with homologous derivatives of the 1,1-dimethyl-3-oxybutyl phosphonic acid / $c E. Pryazhnikov, A. Ostroumov, O. Druginina, F. Vyskočil, A. Skorinkin
- 520 9_
- $a The mode of inhibition of endplate currents by four esters of 1,1-dimethyl-3-oxybutyl phosphonic acid with different lipophilicities and molecule lengths were estimated by mathematical modeling based on previous electrophysiological data supplemented by several experiments with rhythmic stimulation. The aim was to discriminate between their receptor and non-receptor effects. It was shown that all esters have a two-component mechanism of depression: inhibition of the receptor open channel and allosteric modulation of the receptor-channel complex. The ratio of both functional components depends on the length and lipophilicity of the esters. Short and less lipophilic esters mostly act as open channel inhibitors and the rate of inhibition substantially depends on the rate of stimulation, i. e. probability of the receptor-channel opening. As the length of the ester radicals and their lipophilicity increased, these compounds were more active as allosteric receptor inhibitors, probably hindering the function of nAChRs from the lipid annulus.
- 650 _2
- $a alosterická regulace $x účinky léků $7 D000494
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cholinergní antagonisté $x farmakologie $7 D018680
- 650 _2
- $a membránové potenciály $x účinky léků $7 D008564
- 650 _2
- $a nervosvalová ploténka $x účinky léků $x fyziologie $7 D009045
- 650 _2
- $a kyseliny fosforité $x farmakologie $7 D010757
- 650 _2
- $a Rana pipiens $7 D011894
- 650 _2
- $a Ranidae $x fyziologie $7 D011898
- 650 _2
- $a receptory cholinergní $x metabolismus $7 D011950
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ostroumov, A. $u Kazan Federal University, Kazan, Russia
- 700 1_
- $a Druginina, O. $u Kazan Institute of Biochemistry and Biophysics RAS, Kazan, Russia
- 700 1_
- $a Vyskočil, František, $u Institute of Physiology, Academy of Sciences of the Czech Republic and Faculty of Sciences, Charles University, Prague $d 1941- $7 jk01151227
- 700 1_
- $a Skorinkin, A. $u Kazan Federal University, Kazan, Russia; Kazan Institute of Biochemistry and Biophysics RAS, Kazan, Russia; Institute of Informatics, Kazan, Russia
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 61, č. 4 (2012), s. 395-404
- 856 41
- $u http://www.biomed.cas.cz/physiolres/archive.htm $y domovská stránka časopisu - plný text volně přístupný = fulltext
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 3 $z 0
- 990 __
- $a 20131015 $b ABA008
- 991 __
- $a 20131023115041 $b ABA008
- 999 __
- $a ok $b bmc $g 998637 $s 831785
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 61 $c 4 $d 395-404 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK111 $a Pubmed-20131015